Toll/interleukin-1 receptor domain-containing adapter inducing interferon-β mediates microglial phagocytosis of degenerating axons

Journal of Neuroscience

Volumn 32, Issue 22, 2012, Pages 7745-7757

  Hosmane, Suneil ^a   Tegenge, Million Adane ^a   Rajbhandari, Labchan ^a   Uapinyoying, Prech ^a   Kumar, Nishant Ganesh ^a   Thakor, Nitish ^a   Venkatesan, Arun ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL) IMIDAZOLE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ADENOSINE TRIPHOSPHATE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; COCULTURE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; KNOCKOUT MOUSE; MALE; MOUSE; NERVE FIBER DEGENERATION; NERVE FIBER GROWTH; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; TIME-LAPSE VIDEO MICROSCOPY; UPREGULATION; WESTERN BLOTTING;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ADENOSINE TRIPHOSPHATE; ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; ANTIGENS, CD11B; AXONS; AXOTOMY; CELLS, CULTURED; CHEMOKINE CXCL10; COCULTURE TECHNIQUES; DISEASE MODELS, ANIMAL; EMBRYO, MAMMALIAN; ENZYME INHIBITORS; GANGLIA, SPINAL; GENE EXPRESSION REGULATION; HIPPOCAMPUS; HUMANS; IMIDAZOLES; INTERFERON-BETA; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROARRAY ANALYSIS; MICROFLUIDIC ANALYTICAL TECHNIQUES; MICROGLIA; NERVE DEGENERATION; NEURONS; NITRIC OXIDE; PEPTIDES; PHAGOCYTOSIS; PYRIDINES; QUATERNARY AMMONIUM COMPOUNDS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, INTERLEUKIN-1; TIME FACTORS; TRANSFECTION;

EID: 84861589602     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.0203-12.2012     Document Type: Article

References (71)

1. Awasaki T, Ito K (2004) Engulfing action of glial cells is required for programmed axon pruning during Drosophila metamorphosis. Curr Biol 14:668-677.
2. Awasaki T, Tatsumi R, Takahashi K, Arai K, Nakanishi Y, Ueda R, Ito K (2006)Essential role of the apoptotic cell engulfment genes draper and ced-6 in programmed axon pruning during Drosophila metamorphosis. Neuron 50:855-867.
3. Bachstetter AD, Xing B, de Almeida L, Dimayuga ER, Watterson DM, Van Eldik LJ (2011) Microglial p38alpha MAPK is a key regulator of proinflammatory cytokine up-regulation induced by Toll-like receptor (TLR) ligands or beta-amyloid (Abeta). J Neuroinflammation 8:79.
4. Bignami A, Dahl D, Nguyen BT, Crosby CJ (1981) The fate of axonal debris in Wallerian degeneration of rat optic and sciatic nerves. Electron microscopy and immunofluorescence studies with neurofilament antisera. J Neuropathol Exp Neurol 40:537-550.
5. Blander JM, Medzhitov R (2004) Regulation of phagosome maturation by signals from Toll-like receptors. Science 304:1014-1018.
6. Cardona AE, Huang D, Sasse ME, Ransohoff RM (2006) Isolation of murine microglial cells for RNA analysis or flow cytometry. Nat Pro-toc 1:1947-1951.
7. Cavalli V, Vilbois F, Corti M, Marcote MJ, Tamura K, Karin M, Arkinstall S, Gruenberg J (2001) The stress-induced MAP kinase p38 regulates endo-cytic trafficking via the GDI:Rab5 complex. Mol Cell 7:421-432.
8. Cavassani KA, Ishii M, Wen H, Schaller MA, Lincoln PM, Lukacs NW, Ho-gaboam CM, Kunkel SL (2008) TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events. J Exp Med 205:2609-2621.
9. Cekic C, Casella CR, Eaves CA, Matsuzawa A, Ichijo H, Mitchell TC (2009) Selective activation of the p38 MAPK pathway by synthetic monophos-phoryl lipid A. J Biol Chem 284:31982-31991.
10. Choi YJ, Im E, Chung HK, Pothoulakis C, Rhee SH (2010) TRIF mediates Toll-like receptor 5-induced signaling in intestinal epithelial cells. J Biol Chem 285:37570-37578.
11. Coleman M (2005) Axon degeneration mechanisms: commonality amid diversity. Nat RevNeurosci 6:889-898.
12. David S, Lacroix S (2003) Molecular approaches to spinal cord repair. Annu Rev Neurosci 26:411-440.
13. Doyle SE, O'Connell RM, Miranda GA, Vaidya SA, Chow EK, Liu PT, Suzuki S, Suzuki N, Modlin RL, Yeh WC, Lane TF, Cheng G (2004) Toll-like receptors induce a phagocytic gene program through p38. J Exp Med 199:81-90.
14. Dubois-Dalcq M, Ffrench-Constant C, Franklin RJ (2005) Enhancing central nervous system remyelination in multiple sclerosis. Neuron 48:9-12.
15. Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM (1998) Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest 101:890-898.
16. Fenoglio C, Galimberti D, Piccio L, Scalabrini D, Panina P, Buonsanti C, Venturelli E, Lovati C, Forloni G, Mariani C, Bresolin N, Scarpini E (2007) Absence of TREM2 polymorphisms in patients with Alzheimer's disease and frontotemporal lobar degeneration. Neurosci Lett 411:133-137.
17. Franklin RJ, Kotter MR (2008) The biology of CNS remyelination: the key to therapeutic advances. J Neurol 255 [Suppl 1]:19-25.
18. Gais P, Tiedje C, Altmayr F, Gaestel M, Weighardt H, Holzmann B (2010) TRIF signaling stimulates translation of TNF-a mRNA via prolonged activation of MK2. J Immunol 184:5842-5848.
19. George EB, Glass JD, Griffin JW (1995) Axotomy-induced axonal degeneration is mediated by calcium influx through ion-specific channels. J Neurosci 15:6445-6452.
20. George R, Griffin JW (1994) Delayed macrophage responses and myelin clearance during Wallerian degeneration in the central nervous system: the dorsal radiculotomy model. Exp Neurol 129:225-236.
21. Grommes C, Lee CY, Wilkinson BL, Jiang Q, Koenigsknecht-Talboo JL, Var-num B, Landreth GE (2008) Regulation of microglial phagocytosis and inflammatory gene expression by Gas6 acting on the Axl/Mer family of tyrosine kinases. J Neuroimmune Pharmacol 3:130-140.
22. Han KJ, Su X, Xu LG, Bin LH, Zhang J, Shu HB (2004) Mechanisms of the TRIF-induced interferon-stimulated response element and NF-kB activation and apoptosis pathways. J Biol Chem 279:15652-15661.
23. Hasan UA, Caux C, Perrot I, Doffin AC, Menetrier-Caux C, Trinchieri G, Tommasino M, Vlach J (2007) Cell proliferation and survival induced by Toll-like receptors is antagonized by type I IFNs. Proc Natl Acad Sci USA 104:8047-8052.
24. Honda K, Yanai H, Negishi H, Asagiri M, Sato M, Mizutani T, Shimada N, Ohba Y, Takaoka A, Yoshida N, Taniguchi T (2005) IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434:772-777.
25. Hosmane S, Yang IH, Ruffin A, Thakor N, Venkatesan A (2010) Circular compartmentalized microfluidic platform: study of axon-glia interactions. Lab Chip 10:741-747.
26. Imai Y, Kuba K, Neely GG, Yaghubian-Malhami R, Perkmann T, van Loo G, Ermolaeva M, Veldhuizen R, Leung YH, Wang H, Liu H, Sun Y, Paspara-kis M, Kopf M, Mech C, Bavari S, Peiris JS, Slutsky AS, Akira S, Hultqvist M, et al. (2008) Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell 133:235-249.
27. Izaguirre A, Barnes BJ, Amrute S, Yeow WS, Megjugorac N, Dai J, Feng D, Chung E, Pitha PM, Fitzgerald-Bocarsly P (2003) Comparative analysis of IRF and IFN-alpha expression in human plasmacytoid and monocyte-derived dendritic cells. J Leukoc Biol 74:1125-1138.
28. Kanzler H, Barrat FJ, Hessel EM, Coffman RL (2007) Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists. Nat Med 13:552-559.
29. Kariko K, Ni H, Capodici J, Lamphier M, Weissman D (2004) mRNA is an endogenous ligand for Toll-like receptor 3. J Biol Chem 279:12542-12550.
30. Khorooshi R, Owens T (2010) Injury-induced type IIFN signaling regulates inflammatory responses in the central nervous system. J Immunol 185:1258-1264.
31. Kigerl KA, Gensel JC, Ankeny DP, Alexander JK, Donnelly DJ, Popovich PG (2009) Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci 29:13435-13444.
32. Kim JB, Sig Choi J, Yu YM, Nam K, Piao CS, Kim SW, Lee MH, Han PL, Park JS, Lee JK (2006) HMGB1, a novel cytokine-like mediator linking acute neuronal death and delayed neuroinflammation in the postischemic brain. J Neurosci 26:6413-6421.
33. Lee MH, Wang T, Jang MH, Steiner J, Haughey N, Ming GL, Song H, Nath A, Venkatesan A (2011) Rescue of adult hippocampal neurogenesis in a mouse model of HIV neurologic disease. Neurobiol Dis 41:678-687.
34. Loiarro M, Sette C, Gallo G, Ciacci A, Fanto N, Mastroianni D, Carminati P, Ruggiero V (2005) Peptide-mediated interference of TIR domain dimerization in MyD88 inhibits interleukin-1-dependent activation of NF-kB. J Biol Chem 280:15809-15814.
35. Malmgaard L (2004) Induction and regulation of IFNs during viral infections. J Interferon Cytokine Res 24:439-454.
36. Miyanishi M, Tada K, Koike M, Uchiyama Y, Kitamura T, Nagata S (2007) Identification of Tim4 as a phosphatidylserine receptor. Nature 450:435-439.
37. Napoli I, Neumann H (2009) Microglial clearance function in health and disease. Neuroscience 158:1030-1038.
38. Neumann H, Kotter MR, Franklin RJ (2009) Debris clearance by microglia: an essential link between degeneration and regeneration. Brain 132:288-295.
39. Noppert SJ, Fitzgerald KA, Hertzog PJ (2007) The role of type I interferons in TLR responses. Immunol Cell Biol 85:446-457.
40. Okamura Y, Watari M, Jerud ES, Young DW, Ishizaka ST, Rose J, Chow JC, Strauss JF 3rd (2001) The extra domain A of fibronectin activates Tolllike receptor 4. J Biol Chem 276:10229-10233.
41. O'Neill LA, Bowie AG (2007) The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat Rev Immunol 7:353-364.
42. Pais TF, Figueiredo C, Peixoto R, Braz MH, Chatterjee S (2008) Necrotic neurons enhance microglial neurotoxicity through induction of glutam-inase by a MyD88-dependent pathway. J Neuroinflammation 5:43.
43. Pålsson-McDermott EM, O'Neill LA (2007) Building an immune system from nine domains. Biochem Soc Trans 35:1437-1444.
44. Park JS, Svetkauskaite D, He Q, Kim JY, Strassheim D, Ishizaka A, Abraham E (2004) Involvement of Toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem 279:7370-7377.
45. Perry AK, Chen G, Zheng D, Tang H, Cheng G (2005) The host type I interferon response to viral and bacterial infections. Cell Res 15:407-422.
46. Pittock SJ, Lucchinetti CF (2007) The pathology of MS: new insights and potential clinical applications. Neurologist 13:45-56.
47. Ransohoff RM, Perry VH (2009) Microglial physiology: unique stimuli, specialized responses. Annu Rev Immunol 27:119-145.
48. Reed-Geaghan EG, Savage JC, Hise AG, Landreth GE (2009) CD14 and Toll-like receptors 2 and 4 are required for fibrillar A/3-stimulated microglial activation. JNeurosci 29:11982-11992.
49. Rotshenker S, Reichert F, Gitik M, Haklai R, Elad-Sfadia G, Kloog Y (2008) Galectin-3/MAC-2, Ras and PI3K activate complement receptor-3 and scavenger receptor-AI/II mediated myelin phagocytosis in microglia. Glia 56:1607-1613.
50. Stevens B, Allen NJ, Vazquez LE, Howell GR, Christopherson KS, Nouri N, Micheva KD, Mehalow AK, Huberman AD, Stafford B, Sher A, Litke AM, Lambris JD, Smith SJ, John SW, Barres BA (2007) The classical complement cascade mediates CNS synapse elimination. Cell 131:1164-1178.
51. Stewart CR, Stuart LM, Wilkinson K, van Gils JM, Deng J, Halle A, Rayner KJ, Boyer L, Zhong R, Frazier WA, Lacy-Hulbert A, El Khoury J, Golenbock DT, Moore KJ (2010) CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat Immunol 11:155-161.
52. Takahashi K, Rochford CD, Neumann H (2005) Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2. J Exp Med 201:647-657.
53. Takahashi K, Prinz M, Stagi M, Chechneva O, Neumann H (2007) TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis. PLoS Med 4:e124.
54. Tanaka T, Ueno M, Yamashita T (2009) Engulfment of axon debris by microglia requires p38 MAPK activity. J Biol Chem 284:21626-21636.
55. Taylor AM, Jeon NL (2010) Micro-scale and microfluidic devices for neurobiology. Curr Opin Neurobiol 20:640-647.
56. Taylor AM, Blurton-Jones M, Rhee SW, Cribbs DH, Cotman CW, Jeon NL (2005) A microfluidic culture platform for CNS axonal injury, regeneration and transport. Nat Methods 2:599-605.
57. Teige A, Teige I, Lavasani S, Bockermann R, Mondoc E, Holmdahl R, Issazadeh-Navikas S (2004) CD1-dependent regulation of chronic central nervous system inflammation in experimental autoimmune encephalomyelitis. J Immunol 172:186-194.
58. Toshchakov VU, Basu S, Fenton MJ, Vogel SN (2005) Differential involvement of BB loops of Toll-IL-1 resistance (TIR) domain-containing adapter proteins in TLR4- versus TLR2-mediated signal transduction. J Immunol 175:494-500.
59. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L (1998) Axonal transection in the lesions of multiple sclerosis. N Engl J Med 338:278-285.
60. Vallieres N, Berard JL, David S, Lacroix S (2006) Systemic injections of lipopolysaccharide accelerates myelin phagocytosis during Wallerian degeneration in the injured mouse spinal cord. Glia 53:103-113.
61. Vargas ME, Barres BA (2007) Why is Wallerian degeneration in the CNS so slow? Annu RevNeurosci 30:153-179.
62. Voll RE, Herrmann M, Roth EA, Stach C, Kalden JR, Girkontaite I (1997) Immunosuppressive effects of apoptotic cells. Nature 390:350-351.
63. Wang J, Ren L, Li L, Liu W, Zhou J, Yu W, Tong D, Chen S (2009) Micro-fluidics: a new cosset for neurobiology. Lab Chip 9:644-652.
64. Wang R, Yang B, Zhang D (2011) Activation of interferon signaling pathways in spinal cord astrocytes from an ALS mouse model. Glia 59:946-958.
65. Yamamoto M, Sato S, Hemmi H, Sanjo H, Uematsu S, Kaisho T, Hoshino K, Takeuchi O, Kobayashi M, Fujita T, Takeda K, Akira S (2002a) Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4. Nature 420:324-329.
66. Yamamoto M, Sato S, Mori K, Hoshino K, Takeuchi O, Takeda K, Akira S (2002b) Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-/3 promoter in the Toll-like receptor signaling. J Immunol 169:6668-6672.
67. Yamamoto M, Sato S, Hemmi H, Hoshino K, Kaisho T, Sanjo H, Takeuchi O, Sugiyama M, Okabe M, Takeda K, Akira S (2003) Role of adaptor TRIF in the MyD88-independent Toll-like receptor signaling pathway. Science 301:640-643.
68. Zhang J, Jones M, DeBoy CA, Reich DS, Farrell JA, Hoffman PN, Griffin JW, Sheikh KA, Miller MI, Mori S, Calabresi PA (2009) Diffusion tensor magnetic resonance imaging of Wallerian degeneration in rat spinal cord after dorsal root axotomy. JNeurosci 29:3160-3171.
69. Zhang X, Goncalves R, Mosser DM (2008) The isolation and characterization of murine macrophages. Curr Protoc Immunol Chapter 14:Unit 14.1.
70. Ziegenfuss JS, Biswas R, Avery MA, Hong K, Sheehan AE, Yeung YG, Stanley ER, Freeman MR (2008) Draper-dependent glial phagocytic activity is mediated by Src and Syk family kinase signalling. Nature 453:935-939.
71. Zuluaga S, Gutierrez-Uzquiza A, Bragado P, Alvarez-Barrientos A, Benito M, Nebreda AR, Porras A (2007) p38alpha MAPK can positively or negatively regulate Rac-1 activity depending on the presence of serum. FEBS Lett 581:3819-3825.